Not yet recruiting: A new clinical trial sponsored by Istinye University is set to investigate the effects of bruxism on balance, offering critical insights that may have implications for both orthopedic physical therapy practices and medical device development. Clinical and regulatory teams should follow this study’s progress closely, given its potential to inform future guidance and innovation in patient care.
In this article:
- What changed?
- About the clinical trial
- Who is impacted?
- FAQs
- Conclusion
- Disclaimer
- Announcement link
What changed?
This upcoming study, officially titled “The Effect of Bruxism on Balance,” represents a focused effort to understand the impact of bruxism—a condition characterized by excessive grinding of the teeth—on the body's balance mechanisms. While recruitment has not yet started as of January 12, 2026, the trial has been registered on ClinicalTrials.gov, signaling an intent to explore novel therapeutic pathways related to this condition. Such research may ultimately influence downstream medical device applications in these areas.
About the clinical trial
Bruxism remains a prevalent issue within the areas of dentistry and rehabilitative care, often linked to musculoskeletal complications beyond oral health. This trial seeks to explore whether the condition also interferes with stability and balance, areas critical to patient safety and mobility. It is sponsored by Istinye University, a reputable institution in Turkey with a track record of clinical research in physical therapy and related fields.
The trial's approach is interdisciplinary, bridging insights from orthopedic physical therapy and the broader spectrum of musculoskeletal and neurological science. Although specific methodologies have not been disclosed, understanding this potential relationship could guide medical device manufacturers in designing supportive tools such as balance aids or therapeutic sensors tailored to patients with bruxism-related balance issues.
Who is impacted?
The trial findings will be relevant to multiple stakeholders:
- Clinical professionals: Physiotherapists, neurologists, and dental experts may gain deeper insights into the ripple effects of bruxism on their patients.
- Medical device developers: Manufacturers working on balance-monitoring or corrective devices could leverage these results to design patient-specific solutions.
- Regulatory bodies: Such evidence-driven developments may shape new regulatory recommendations or requirements for devices aimed at treating balance impairments.
- Patients: Those affected by bruxism could see expanded care options or earlier interventions based on the study's outcomes.
FAQ
1. What is bruxism?
Bruxism refers to excessive grinding or clenching of teeth, often occurring unconsciously during sleep or waking hours. It is associated with various oral health, musculoskeletal, and neurological issues.
2. Why could bruxism affect balance?
The condition may alter bodily posture or muscle tension, potentially disrupting overall equilibrium. This link is one of the hypotheses this study aims to explore.
3. Is this trial funded by a government agency?
No, the trial is sponsored by Istinye University, an educational and research institution. It is not linked to a government agency at this stage.
Conclusion
The upcoming clinical trial on bruxism and balance, spearheaded by Istinye University, stands to uncover critical correlations that may influence therapeutic practices and medical device innovation. Regulatory and quality professionals should monitor these developments, as they could have significant implications across clinical and commercial domains.
Disclaimer
This article is for informational purposes only and does not constitute legal or clinical advice. Professionals should consult relevant regulatory sources for compliance requirements.
Announcement link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07308145?term=medical+device